POLYISOBUTYLENE URETHANE, UREA AND URETHANE/UREA COPOLYMERS AND MEDICAL DEVICES CONTAINING THE SAME

• US 20090326077A1
• Filed: 06/26/2009
• Published: 12/31/2009
• Est. Priority Date: 06/27/2008
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Schwarz, Marlene C., Desai, Shrojalkumar, Krishnan, Mohan, Cooke, Daniel J., Boden, Mark, Strickler, Frederick H., Smith, Michael C.
• Application Number:
  US12/492,440
• Publication Number:
  US 20090326077A1
• Time in Patent Office: Days
• US Class Current: 514/772.3
• CPC Class Codes: A61L 27/18 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: A61L 31/06 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/041 takes precedence
• CPC Class Codes: C08G 18/10 Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
• CPC Class Codes: C08G 18/12 using two or more compounds having active hydrogen in the first polymerisation step
• CPC Class Codes: C08G 18/3206 aliphatic
• CPC Class Codes: C08G 18/4063 Mixtures of compounds of group C08G18/62 with other macromolecular compounds
• CPC Class Codes: C08G 18/4854 Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group
• CPC Class Codes: C08G 18/4858 Polyethers containing oxyalkylene groups having more than four carbon atoms in the alkylene group
• CPC Class Codes: C08G 18/6204 Polymers of olefins unsaturated polymers of conjugated dienes C08G18/69
• CPC Class Codes: C08G 18/6511 compounds of group C08G18/3203
• CPC Class Codes: C08G 18/7657 containing two or more aromatic rings
• CPC Class Codes: C08L 75/00 Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers

Abstract

The present invention pertains to polyisobutylene urethane, urea and urethane/urea copolymers, to methods of making such copolymers and to medical devices that contain such polymers. According to certain aspects of the invention, polyisobutylene urethane, urea and urethane/urea copolymers are provided, which comprise a polyisobutylene segment, an additional polymeric segment that is not a polyisobutylene segment, and a segment comprising a residue of a diisocyanate. According to other aspects of the invention, polyisobutylene urethane, urea and urethane/urea copolymers are provided, which comprise a polyisobutylene segment and end groups that comprise alkyl-, alkenyl- or alkynyl-chain-containing end groups.

Claims

1. A polyisobutylene urethane, urea or urethane/urea copolymer comprising a polyisobutylene segment, an additional polymeric segment that is not a polyisobutylene segment, and a segment comprising a residue of a diisocyanate.

2. The copolymer of claim 1, wherein the additional polymeric segment is a soft polymeric segment.

3. The copolymer of claim 2, wherein the soft polymeric segment is selected from a polyether segment, a fluoropolymer segment, a polyester segment, a polyacrylate segment, a polymethacrylate segment, a polysiloxane segment and a polycarbonate segment.

4. The copolymer of claim 2, wherein the additional polymeric segment is selected form a polytetramethylene oxide segment, a polydimethylsiloxane segment, a polyperfluoroalkylene oxide segment, a polyhexamethylene carbonate segment.

5. The copolymer of claim 1, wherein the polyisobutylene segment comprises a residue of a polyisobutylene diol or a polyisobutylene diamine and wherein the additional polymeric segment comprises a residue of a polymeric diol or diamine selected from a polytetramethylene oxide diol, a polytetramethylene oxide diamine, a polydimethylsiloxane diol, a polydimethylsiloxane diamine, a polyperfluoroalkylene oxide diol, a polyperfluoroalkylene oxide diamine, a polyhexamethylene carbonate diol and a polyhexamethylene carbonate diamine.

6. The copolymer of claim 1, wherein the diisocyanate is selected from 4,4′

-methylenediphenyl diisocyanate, toluene diisocyanate, 1,5-naphthalene diisocyanate, para-phenylene diisocyanate, 3,3′

-tolidene-4,4′

-diisocyanate, 3,3′

-dimethyl-diphenylmethane-4,4′

-diisocyanate, and combinations thereof.

7. The copolymer of claim 1, further comprising a chain extender residue.

8. The copolymer of claim 7, wherein the chain extender residue is selected from an aliphatic diol, an aromatic diol, an aliphatic diamine or an aromatic diamine.

9. The copolymer of claim 7, wherein the chain extender is an alpha,omega-C1-C10-alkane diol.

10. The copolymer of claim 7, wherein the chain extender is selected from 1,2-ethane diol, 1,4-butanediol and 1,6-hexanediol, a low molecular weight polyisobutylene diol, and a low molecular weight poly(stryene-b-isobutylene-b-styrene) diol.

11. The copolymer of claim 1, further comprising end groups that comprise alkyl, alkenyl or alkynyl chains ranging from 1 to 17 carbons atoms in length.

12. The copolymer of claim 11, wherein the end groups are selected from [—

CH₂]_n—

CH₃ groups, [—

CH₂]_n—

CF₃ groups, [—

CH₂]_n—

C₆H₅ groups and combinations thereof, where n ranges from 1 to 17.

13. The copolymer of claim 1, wherein the additional polymeric segment is a hard polymeric segment.

14. The copolymer of claim 13, wherein the additional polymeric segment is selected from a poly(vinyl aromatic) segment, a poly(alkyl acrylate) segment and a poly(alkyl methacrylate) segment.

15. The copolymer of claim 13, wherein the additional polymeric segment is a polystyrene segment.

16. The copolymer of claim 15, wherein the polyisobutylene segment comprises a residue of a polyisobutylene diol and wherein the polystyrene segment comprises a residue of a polystyrene diol.

17. The copolymer of claim 15, comprising a poly(styrene-b-isobutylene-b-styrene) diol residue.

18. An implantable or insertable medical device comprising a polymeric region that comprises the copolymer of claim 1.

19. The implantable or insertable medical device of claim 18, wherein the medical device is selected from an implantable electrical lead, a pacemaker, a defibrillator and a heart failure device.

20. The implantable or insertable medical device of claim 18, wherein the medical device comprises an implantable electrical lead and wherein the polymeric region is a polymeric layer disposed over an electrical conductor.

21. The implantable or insertable medical device of claim 20, wherein the electrical lead is selected from a cardiac lead and a neurostimulation lead.

22. The implantable or insertable medical device of claim 18, wherein said polymeric region further comprises a therapeutic agent.

23. The implantable or insertable medical device of claim 18, wherein said polymeric region further comprises an additional material selected from a silicate material, alumina, silver nanoparticles, and silicate/alumina/silver nanoparticle composites.

24. A polyisobutylene urethane, urea or urethane/urea copolymer comprising a polyisobutylene segment and further comprising end groups that comprise alkyl, alkenyl or alkynyl chains ranging from 1 to 17 carbon atoms in length.

25. The copolymer of claim 24, wherein the end groups comprise moieties selected from [—

CH₂]_n—

CH₃ groups, [—

CH₂]_n—

CF₃ groups, [—

CH₂]_n—

C₆H₅ groups and combinations thereof, where n ranges from 1 to 17.

26. An implantable or insertable medical device comprising a polymeric region that comprises the copolymer of claim 24.